Key facts
- This page summarizes Anne Nagengast Johnson's Form 4 filing for ATAI Life Sciences N.V. (ATAI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 19 Mar 2025, 19:29.
Anne Nagengast Johnson - 14 Mar 2025 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ATAI
- Reported as of
- 14 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Mar 2025, 19:29:43 UTC
- Prior SEC filing
- 05 Mar 2025
- Next SEC filing
- 24 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ryan Barrett, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Anne Nagengast Johnson filed Form 4 for ATAI Life Sciences N.V. (ATAI) on 19 Mar 2025.
Change
- Previous filing in this sequence was filed on 05 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATAI
transaction
Common Shares
Options Exercise
- Transaction value
- Shares
- +100,000
- Change %
- +136%
- Price
- Shares after
- 173,590
- Date
- 14 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATAI
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -100,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 14 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 100,000
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Each restricted stock unit represents a contingent right to receive one common share of the Issuer upon vesting and settlement. 50% of the restricted stock units vested on March 14, 2024, the first anniversary of the grant date and 50% vested on March 14, 2025, the second anniversary of the grant date.